Afya (AFYA) Expected to Announce Quarterly Earnings on Thursday

Afya (NASDAQ:AFYA) will likely be posting its Q4 2025 results before the market opens on Thursday, March 12th. Analysts expect the company to announce earnings of $0.36 per share and revenue of $174.7420 million for the quarter. Investors can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Thursday, March 12, 2026 at 5:00 PM ET.

Afya Stock Up 0.2%

NASDAQ:AFYA opened at $14.04 on Wednesday. Afya has a one year low of $13.00 and a one year high of $19.90. The company has a debt-to-equity ratio of 0.21, a current ratio of 0.98 and a quick ratio of 0.98. The company has a market cap of $1.32 billion, a PE ratio of 10.10, a P/E/G ratio of 0.63 and a beta of 0.52. The firm’s 50 day simple moving average is $14.49 and its 200 day simple moving average is $14.79.

Wall Street Analysts Forecast Growth

AFYA has been the topic of a number of recent research reports. Wall Street Zen lowered shares of Afya from a “strong-buy” rating to a “buy” rating in a report on Saturday, January 31st. Bank of America lowered Afya from a “buy” rating to a “neutral” rating and lowered their target price for the stock from $22.00 to $17.00 in a research report on Tuesday, February 24th. Sanford C. Bernstein raised Afya to a “market perform” rating in a report on Friday, January 16th. Weiss Ratings reissued a “hold (c)” rating on shares of Afya in a research note on Wednesday, January 21st. Finally, JPMorgan Chase & Co. restated a “neutral” rating and set a $22.00 price objective (down from $24.50) on shares of Afya in a research report on Wednesday, January 7th. One equities research analyst has rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $17.30.

Institutional Trading of Afya

A number of large investors have recently bought and sold shares of the business. Jump Financial LLC bought a new position in shares of Afya during the 2nd quarter worth about $731,000. Qube Research & Technologies Ltd bought a new stake in Afya in the 3rd quarter valued at about $610,000. Lazard Asset Management LLC raised its stake in Afya by 167.6% during the 3rd quarter. Lazard Asset Management LLC now owns 49,399 shares of the company’s stock worth $771,000 after buying an additional 30,936 shares during the period. Goldman Sachs Group Inc. raised its stake in Afya by 167.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 45,093 shares of the company’s stock worth $809,000 after buying an additional 28,226 shares during the period. Finally, Susquehanna International Group LLP acquired a new stake in Afya in the third quarter valued at approximately $419,000. 88.02% of the stock is currently owned by institutional investors and hedge funds.

About Afya

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.